Please send us your questions to the email address below, and we will respond as soon as possible.

 

General inquiries

info@covid19immunitytaskforce.ca

 

Media inquiries

media@covid19immunitytaskforce.ca

Rebecca Burns, Communications Advisor

Rebecca.anne.burns@mcgill.ca, +1.438.871.8763

Caroline Phaneuf, Communications Manager

Caroline.phaneuf@mcgill.ca, +1.514.444.4532

 

Researcher inquiries

For questions about funding opportunities and the application process:

proposals@covid19immunitytaskforce.ca

For post-award administration:

admin1.citf@mcgill.ca

To submit a preprint or publication for inclusion in our Research Roundup newsletter:

research@covid19immunitytaskforce.ca

 

Mailing address and reception

The COVID-19 Immunity Task Force Secretariat is housed at the McGill University School of Population and Global Health:

Cascades Building

772 Sherbrooke Street West

3rd Floor

Montréal, QC

H3A 1G1

 

Frequently Asked Questions

Seeking information on vaccine procurement and rollout?

The COVID-19 Vaccine Task Force advises the federal government on COVID-19 vaccine procurement and the National Advisory Committee on Immunization (NACI) advises the federal, provincial and territorial governments on vaccine delivery policy and priorities. Vaccine rollout plans are determined at the provincial level.

Seeking a test for antibodies against SARS-CoV-2, the virus that causes COVID-19?

We continue to receive requests for antibody testing from people who recall having had symptoms suggestive of COVID-19 disease but who never received a positive test for the active infection. Our mandate is to generate estimates of population level immunity, via large-scale studies. As such, we are unable to provide antibody tests to individuals. If you are interested in participating in a seroprevalence study, you may visit https://covidtrials.ca/